Mackay Shields LLC’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-34,871
| Closed | -$6.41M | – | 722 |
|
|
2021
Q2 | $6.41M | Sell |
34,871
-1,705
| -5% | -$313K | 0.06% | 284 |
|
|
2021
Q1 | $5.59M | Sell |
36,576
-39,424
| -52% | -$6.03M | 0.04% | 449 |
|
|
2020
Q4 | $11.9M | Sell |
76,000
-130,512
| -63% | -$20.4M | 0.08% | 274 |
|
|
2020
Q3 | $23.6M | Buy |
206,512
+96,674
| +88% | +$11.1M | 0.16% | 134 |
|
|
2020
Q2 | $12.3M | Buy |
109,838
+47,998
| +78% | +$5.39M | 0.1% | 239 |
|
|
2020
Q1 | $5.55M | Buy |
61,840
+6,042
| +11% | +$542K | 0.05% | 371 |
|
|
2019
Q4 | $6.04M | Sell |
55,798
-4,041
| -7% | -$437K | 0.04% | 426 |
|
|
2019
Q3 | $5.86M | Buy |
59,839
+9,183
| +18% | +$899K | 0.04% | 452 |
|
|
2019
Q2 | $6.64M | Buy |
50,656
+1,538
| +3% | +$201K | 0.05% | 436 |
|
|
2019
Q1 | $6.64M | Buy |
49,118
+4,615
| +10% | +$624K | 0.05% | 420 |
|
|
2018
Q4 | $4.33M | Buy |
+44,503
| New | +$4.33M | 0.04% | 501 |
|
|
2018
Q3 | – | Sell |
-48,383
| Closed | -$6.01M | – | 1264 |
|
|
2018
Q2 | $6.01M | Sell |
48,383
-2,874
| -6% | -$357K | 0.04% | 439 |
|
|
2018
Q1 | $5.71M | Buy |
+51,257
| New | +$5.71M | 0.04% | 474 |
|